🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/06/2008 | 36,82 | 36,89 | 35,72 | 35,77 | -3,60% | 3,19% | 23.024.455 |
| 05/06/2008 | 36,61 | 37,19 | 36,35 | 37,11 | +1,89% | 2,32% | 14.073.382 |
| 04/06/2008 | 36,38 | 36,67 | 36,34 | 36,42 | -0,47% | 0,92% | 12.106.496 |
| 03/06/2008 | 36,53 | 36,80 | 36,30 | 36,59 | +0,47% | 1,38% | 12.858.122 |
| 02/06/2008 | 37,18 | 37,20 | 36,16 | 36,42 | -2,03% | 2,80% | 20.430.446 |
| 30/05/2008 | 37,32 | 37,46 | 36,77 | 37,18 | +0,10% | 1,87% | 14.605.662 |
| 29/05/2008 | 36,90 | 37,68 | 36,76 | 37,14 | +0,67% | 2,51% | 16.980.220 |
| 28/05/2008 | 37,02 | 37,08 | 36,48 | 36,89 | +0,10% | 1,62% | 12.375.832 |
| 27/05/2008 | 37,15 | 37,57 | 36,59 | 36,85 | -0,31% | 2,62% | 19.701.247 |
| 23/05/2008 | 37,20 | 37,44 | 36,95 | 36,97 | -0,74% | 1,33% | 10.843.237 |
| 22/05/2008 | 37,33 | 37,55 | 36,88 | 37,24 | -0,26% | 1,79% | 11.380.966 |
| 21/05/2008 | 37,91 | 38,25 | 37,21 | 37,34 | -1,53% | 2,74% | 13.393.859 |
| 20/05/2008 | 37,97 | 38,60 | 37,79 | 37,92 | -0,70% | 2,14% | 11.582.915 |
| 19/05/2008 | 38,12 | 38,26 | 37,95 | 38,19 | +0,05% | 0,83% | 15.046.974 |
| 16/05/2008 | 38,37 | 38,37 | 37,81 | 38,17 | +0,00% | 1,44% | 12.546.551 |
| 15/05/2008 | 38,00 | 38,25 | 37,66 | 38,17 | +0,43% | 1,56% | 14.361.687 |
| 14/05/2008 | 37,47 | 38,16 | 37,38 | 38,01 | +1,68% | 2,09% | 13.692.854 |
| 13/05/2008 | 37,69 | 38,01 | 37,16 | 37,38 | -1,14% | 2,25% | 13.219.158 |
| 12/05/2008 | 37,22 | 37,88 | 37,19 | 37,81 | +1,62% | 1,85% | 10.744.515 |
| 09/05/2008 | 37,21 | 37,81 | 36,74 | 37,20 | -0,26% | 2,87% | 13.198.617 |
| 08/05/2008 | 37,43 | 37,91 | 36,86 | 37,30 | +0,20% | 2,80% | 11.881.386 |
| 07/05/2008 | 37,07 | 37,68 | 37,07 | 37,22 | +0,44% | 1,65% | 17.530.525 |
| 06/05/2008 | 37,19 | 37,21 | 36,75 | 37,06 | -0,36% | 1,26% | 10.940.806 |
| 05/05/2008 | 37,57 | 37,60 | 37,12 | 37,19 | -0,99% | 1,27% | 10.946.674 |
| 02/05/2008 | 37,14 | 37,69 | 37,00 | 37,57 | +1,08% | 1,85% | 17.978.335 |
| 01/05/2008 | 36,08 | 37,25 | 36,07 | 37,17 | +2,39% | 3,28% | 25.145.083 |
| 30/04/2008 | 35,69 | 36,40 | 35,11 | 36,30 | +2,42% | 3,61% | 39.215.741 |
| 29/04/2008 | 36,49 | 36,64 | 35,28 | 35,44 | -10,38% | 3,74% | 84.372.908 |
| 28/04/2008 | 38,88 | 39,79 | 38,88 | 39,54 | +1,77% | 2,33% | 14.188.767 |
| 25/04/2008 | 38,24 | 39,06 | 38,17 | 38,86 | +1,88% | 2,35% | 14.503.901 |